# Flow Cytometric Analysis of Peripheral Blood Neutrophil Myeloperoxidase Expression for Ruling Out Myelodysplastic Syndromes: Protocol for a Diagnostic Accuracy Study

> **NCT05175469** · — · UNKNOWN · sponsor: **University Hospital, Grenoble** · enrollment: 400 (estimated)

## Conditions studied

- Myelodysplastic Syndromes

## Interventions

- **DIAGNOSTIC_TEST:** Flow cytometric analysis of neutrophil myeloperoxidase expression

## Key facts

- **NCT ID:** NCT05175469
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-01
- **Primary completion:** 2025-01
- **Final completion:** 2025-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05175469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05175469, "Flow Cytometric Analysis of Peripheral Blood Neutrophil Myeloperoxidase Expression for Ruling Out Myelodysplastic Syndromes: Protocol for a Diagnostic Accuracy Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05175469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*